Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell

Cytotherapy

Volumn 18, Issue 3, 2016, Pages 413-422

  Sun, Li ^a   Xu, Rongman ^a   Sun, Xiaoxian ^a   Duan, Yuping ^a   Han, Yiwen ^a   Zhao, Yuanyuan ^a   Qian, Hui ^a   Zhu, Wei ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

exosomes; human umbilical cord; mesenchymal stromal cell; safety

Indexed keywords

PYROGEN;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; EXOSOME; FEMALE; GUINEA PIG; HEMOLYSIS; HISTOLOGY; HUMAN; HUMAN CELL; INCUBATION TIME; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MESENCHYMAL STROMA CELL; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECTUM TEMPERATURE; STAINING; SYSTEMIC ANAPHYLAXIS; TAIL VEIN; UMBILICAL CORD; UMBILICAL CORD MESENCHYMAL STROMAL CELL; WEIGHT REDUCTION; ADVERSE EFFECTS; ANIMAL; CELL CULTURE; CYTOLOGY; LIVER; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RABBITS AND HARES; SPRAGUE DAWLEY RAT; TRANSPLANTATION; ULTRASTRUCTURE;

ANIMALS; CELLS, CULTURED; EXOSOMES; FEMALE; GUINEA PIGS; HEMOLYSIS; HUMANS; LIVER; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; UMBILICAL CORD;

EID: 84964381178     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.11.018     Document Type: Article

References (27)

1. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 2009;11:503-15.
2. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011;6:481-92.
3. Poh KK, Sperry E, Young RG, Freyman T, Barringhaus KG, Thompson CA. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high doses, "off-The-shelf," cellular cardiomyoplasty strategy. Int J Cardiol 2007;117:360-4.
4. Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 2009;77:370-6.
5. Zhu W, Huang L, Li Y, Qian H, Shan X, Yan Y, et al. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle 2011;10:3198-207.
6. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007;110:1362-9.
7. Ferrand J, Noël D, Lehours P, Prochazkova-Carlotti M, Chambonnier L, Ménard A, et al. Human bone marrowderived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS ONE 2011;6:e19569.
8. Freeman BT, Kouris NA, Ogle BM. Tracking fusion of human mesenchymal stem cells after transplantation to the heart. Stem CellsTransl Med 2015;4:685-94.
9. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-4.
10. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25:2896-902.
11. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci 2014;15:4142-57.
12. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581-93.
13. Qin J, Xu Q. Functions and application of exosomes. Acta Pol Pharm 2014;71:537-43.
14. O'Loughlin AJ,Woffindale CA,Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 2012;12:262-74.
15. Wahlgren J, Statello L, Skogberg G, Telemo E, Valadi H. Delivery of small interfering RNAs to cells via exosomes. Methods Mol Biol 2016;1364:105-25.
16. Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009;9:4997-5000.
17. Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, et al. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Ther 2006;13:289-300.
18. Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008;32:8-15.
19. Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 2009;41:875-80.
20. Zhao Y, Sun X, Cao W, Ma J, Sun L, Qian H, et al. Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury. Stem Cells Int 2015;2015: http://dx.doi.org/10.1155/2015/ 761643 .
21. Chen X, Zhang L, Su T, Li H, Huang Q,Wu D, et al. Kinetics of plasma microRNA-499 expression in acute myocardial infarction. J Thorac Dis 2015;7:890-6.
22. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 2012;315:28-37.
23. Su F, Zhang W, Liu J. Membrane estrogen receptor alpha is an important modulator of bone marrow C-Kit(+) cells mediated cardiac repair after myocardial infarction. Int J Clin Exp Pathol 2015;8:4284-95.
24. Lamont EB, Christakis NA, Lauderdale DS. Favorable cardiac risk among elderly breast carcinoma survivors. Cancer 2003;98:2-10.
25. Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells 2015;33:2158-68.
26. Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013;22:845-54.
27. Zhou Y, Xu H, Xu W,Wang B,Wu H, Tao Y, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013;4:34.